glp 1 covid Medscape | GLP-1 receptor agonists such as semaglutide are changing the way type 2 diabetes and obesity are treated. But these drugs have also shown a There isn't enough data to

With that in mind, lets take a closer look at both the common and less common side effects of GLP-1 medications, as well as practical management strategies to help mitigate any discomfort or complications

Book Consultation 54.99 This article is for educational purposes only and does not replace personalised medical advice

This is almost half a milliliter, which means you are drawing nearly half the syringe on a standard 1ml insulin syringe

If you experience severe, persistent abdominal pain (particularly if radiating to the back), you should stop taking the medication and seek urgent medical care, as this could indicate pancreatitis

The Reward System: GLP-1 also modulates the brains reward pathways, particularly areas rich in dopamine receptors

The LEADER trial (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) studies showed no significant increase in pancreatitis rates compared to placebo